000028 国药一致
2025/06 - 中期
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额15,0673,271,4682,937,1392,560,4311,655,181
投资活动产生之现金流量净额(64,068)(150,686)(135,435)(342,819)(455,532)
筹资活动产生之现金流量净额(662,840)(1,831,236)(2,407,642)(1,507,760)(1,871,641)
汇率变动对现金及现金等价物的影响(75)(1,196)(941)(1,190)391
现金及现金等价物净增加/(减少)(711,916)1,288,350393,121708,661(671,601)
期初现金及现金等价物余额7,123,6455,835,2945,442,1734,733,5125,405,113
期末现金及现金等价物余额6,411,7297,123,6455,835,2945,442,1734,733,512